Class IIa HDAC inhibitor MC1568 inhibits EMT-mediated renal fibrosis by inhibiting the activation of TGF-β/SMAD3 and the NF-κb signaling pathway, and upregulating the expression of BMP-7, KLOTHO protein [113]. Here, NFKB1 is linked to renal fibrosis.